Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-278770
Filing Date
2023-11-16
Accepted
2023-11-16 16:02:02
Documents
2
Group Members
JOHNSON & JOHNSON

Document Format Files

Seq Description Document Type Size
1 SC 13G d568772dsc13g.htm SC 13G 49595
2 EX-99.A d568772dex99a.htm EX-99.A 3805
  Complete submission text file 0001193125-23-278770.txt   54959
Mailing Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901
Business Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901 (732) 524-3218
Johnson & Johnson Innovation - JJDC, Inc. (Filed by) CIK: 0000924020 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13G

Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Subject) CIK: 0001760854 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91935 | Film No.: 231414544
SIC: 2834 Pharmaceutical Preparations